Stay updated on Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, indicating a new release with potentially significant changes, while the previous version v2.9.7 has been removed.
    Difference
    0.4%
    Check dated 2024-07-23T14:36:36.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T07:49:51.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-07-02T14:23:03.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-27T10:12:54.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the version of the content on the webpage.
    Difference
    0.1%
    Check dated 2024-06-26T09:01:16.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The recent change in the web page value from 'Show more' to 'Show less' represents an update indicating a reduction in the displayed content related to the study details and interventions for the clinical trial on Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases.
    Difference
    22%
    Check dated 2024-06-25T08:28:45.000Z thumbnail image

Stay in the know with updates to Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Yttrium90 Ipilimumab Nivolumab in Uveal Melanoma Clinical Trial page.